THE Medicines Control Authority of Zimbabwe (MCAZ), has approved the use of Johnson & Johnson vaccine in Zimbabwe in the management and prevention of COVID-19 infections. By Michael Gwarisa In an interview with HealthTimes, MCAZ Projects and Public Relations Officer, Mr Shingai Gwatidzo confirmed the development. MCAZ reviewed the technical documentation and clinical studies conducted and issued Emergency Use Authorisation for Ministry of Health and Child Care to consider adding to the vaccines for use in Zimbabwe,” said Mr Gwatidzo. He added that the EUA is subject to a number…
Read More